Misconceptions About Genetic and Genomic Testing

Andrey Antov, PhD, MBA

Video Categories: 2018 AONN Midyear and Video Library

Dr Andrey Antov notes that there is often confusion around genetic and genomic testing, due in part to a lack of genetic counselors, high costs, and the rate of adoption of new technologies.

July 25, 2018

What the Next Generation of Cancer Biomarkers May Involve

Dr Sanjiv Agarwala predicts that the cancer biomarkers of the future may be “mobile biomarkers,” meaning measures of the tumor microenvironment or immune response that change with therapy and may be able to determine treatment efficacy.

September 2, 2015

Aspirations for the Launch of Ixazomib

Ixazomib may have the potential for great combinability with other drugs, according to Dixie-Lee Esseltine, MD and George Mulligan, PhD. Combination therapy improves compliance, adherence, and quality of life among patients.